Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00830024 · ClinicalTrials.gov registry record · Phase 1

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

A Phase 1 study of Healthy, sponsored by Teva Pharmaceuticals U.

Completed
Registry status
Phase 1
Development phase
36
Enrollment target
2
Study locations

NCT00830024 is a Phase 1 study of Healthy that has completed, run by Teva Pharmaceuticals U. The registered enrollment target is 36 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00830024, a Phase 1 study of Healthy, has completed, sponsored by Teva Pharmaceuticals U.

COMPLETED
Registry status
Phase 1
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

This study will compare the relative bioavailability (rate and extent of absorption) of 3 mg Alprazolam Extended Release Tablets manufactured and distributed by TEVA Pharmaceuticals USA with that of 3 mg XANAX XR® Tablets by Pharmacia \& Upjohn Company following a single oral dose (1 x 3 mg extended release tablet) in healthy adult subjects administered under non-fasting conditions.

Conditions Studied

Healthy

Interventions

  • DRUG Alprazolam Extended-Release 3 mg Tablets

Study Locations (2)

Minnesota

  • PRACS Institute, Ltd. - East Grand Forks

North Dakota

  • PRACS Institute, Ltd. - Fargo

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2005-06
Est. Completion 2005-06
Phase Phase 1

Sponsor

Teva Pharmaceuticals U

19 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00830024

The ClinicalTrials.gov registry entry for NCT00830024 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Teva Pharmaceuticals U, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Alprazolam Extended-Release 3 mg Tablets is the first listed.

NCT00830024 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, North Dakota.

Frequently Asked Questions

What is clinical trial NCT00830024 about?

NCT00830024 is a clinical study titled "Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions". This study will compare the relative bioavailability (rate and extent of absorption) of 3 mg Alprazolam Extended Release Tablets manufactured and distributed by TEVA Pharmaceuticals USA with that of 3 mg XANAX XR® Tablets by Pharmacia \& Upjohn Company following a single oral dose (1 x 3 mg extended...

What is the current status of trial NCT00830024?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2005-06. Estimated completion is 2005-06.

What conditions does trial NCT00830024 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00830024?

The interventions under investigation include: Alprazolam Extended-Release 3 mg Tablets (DRUG).

Who is sponsoring clinical trial NCT00830024?

This trial is sponsored by Teva Pharmaceuticals U, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00830024 being conducted?

This trial has 2 study locations across Minnesota, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.